Search results for "Lipoprotein transport"

showing 2 items of 2 documents

Cell-mediated lipoprotein transport: A novel anti-atherogenic concept

2010

Lipoprotein transport is thought to occur in the plasma compartment of the blood, where lipoproteins are modulated by various enzymatic reactions. Subsequently, lipoproteins can migrate through the endothelial barrier to the subendothelial space or are taken up by the liver. The interaction between pro-atherogenic (apoB-containing) lipoproteins and blood cells (especially monocytes and macrophages) in the subendothelial space is well known. This lipoprotein-inflammatory cell interplay is central in the development of the atherosclerotic plaque. In this review, a novel interaction is described between lipoproteins and both leukocytes and erythrocytes in the blood compartment. This lipoprotei…

ErythrocytesApolipoprotein BLipoproteinsComplement receptor 1Blood lipidsLeukocytesInternal MedicinemedicineAnimalsHumansEndothelial dysfunctionComplement ActivationApolipoproteins BbiologyBiological TransportGeneral MedicineLipoprotein(a)Atherosclerosismedicine.diseaseComplement systemCell biologyLiverBiochemistryLipoprotein transportbiology.proteinlipids (amino acids peptides and proteins)Inflammation Mediatorsbiology.geneCardiology and Cardiovascular MedicineLipoproteinAtherosclerosis Supplements
researchProduct

Erythrocyte-associated apolipoprotein B and its relationship with clinical and subclinical atherosclerosis

2011

Eur J Clin Invest 2012; 42 (4): 365–370 Abstract Background  Apolipoprotein (apo) B-containing lipoproteins are closely linked to atherogenesis. These lipoproteins are transported in plasma and are also associated with blood leucocytes. Our aim was to investigate whether apoB-containing lipoproteins are also present on the surface of erythrocytes and investigate the relationship with the presence of atherosclerosis in a cross-sectional study. Materials and methods  Erythrocyte-bound apoB (ery-apoB) was measured by flowcytometry in subjects with (CAD+) and without coronary artery disease (CAD−), based on coronary angiography or on a history of cardiovascular disease. Intima media thickness (…

medicine.medical_specialtyEndotheliumApolipoprotein Bbiologybusiness.industryClinical BiochemistryGeneral MedicineNegative associationmedicine.diseaseLower riskBiochemistryCoronary artery diseasemedicine.anatomical_structureEndocrinologyIntima-media thicknessSubclinical atherosclerosisLipoprotein transportInternal medicinemedicinebiology.proteinlipids (amino acids peptides and proteins)businessEuropean Journal of Clinical Investigation
researchProduct